APA (7th ed.) Citation

Fox, M. L., García-Cadenas, I., Navarro, V., Martínez, A. P., Kara, M., Bazán, I. S., . . . Valcárcel, D. (2024). Post-transplant cyclophosphamide compared to sirolimus/tacrolimus in reduced intensity conditioning transplants for patients with lymphoid malignancies. Bone Marrow Transplantation: Official journal of the European Society for Blood and Marrow Transplantation, 59(10), 1369. https://doi.org/10.1038/s41409-024-02322-2

Chicago Style (17th ed.) Citation

Fox, Maria Laura, et al. "Post-transplant Cyclophosphamide Compared to Sirolimus/tacrolimus in Reduced Intensity Conditioning Transplants for Patients with Lymphoid Malignancies." Bone Marrow Transplantation: Official Journal of the European Society for Blood and Marrow Transplantation 59, no. 10 (2024): 1369. https://doi.org/10.1038/s41409-024-02322-2.

MLA (9th ed.) Citation

Fox, Maria Laura, et al. "Post-transplant Cyclophosphamide Compared to Sirolimus/tacrolimus in Reduced Intensity Conditioning Transplants for Patients with Lymphoid Malignancies." Bone Marrow Transplantation: Official Journal of the European Society for Blood and Marrow Transplantation, vol. 59, no. 10, 2024, p. 1369, https://doi.org/10.1038/s41409-024-02322-2.